Aetion CEO Carolyn Magill Explains How Aetion Will Collect Evidence to Prove What Medicines Work

In this week’s Breaking Health Podcast, recently installed Aetion CEO Carolyn Magill visits with BH host Steve Krupa to share the value-based healthcare story that helped the company raise $36.4 million in a Series B from investors including New Enterprise Associates.